Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2000
11/02/2000WO2000033878A3 Stabilization of macrolides
11/02/2000WO2000029029A9 Compositions and methods for producing vascular occlusion
11/02/2000WO2000018932A3 Receptor based antagonists and methods of making and using
11/02/2000WO2000012508B1 Pyrrolbenzodiazepines
11/02/2000WO1999063973A3 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1048299A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/02/2000EP1047788A2 Metastatic breast and colon cancer regulated genes
11/02/2000EP1047774A1 Methods and compositions for gene delivery
11/02/2000EP1047772A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047713A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047712A1 Fatty acid synthase mrna binding protein
11/02/2000EP1047694A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
11/02/2000EP1047682A1 Recovery of taxanes from plant material
11/02/2000EP1047676A1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000EP1047457A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
11/02/2000EP1047456A1 A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents
11/02/2000EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use
11/02/2000EP1047433A1 Cellulose derivatives and colorectal cancer risk reduction
11/02/2000EP1047425A1 Integrin receptor antagonists
11/02/2000EP1047422A1 Use of histamine for elevating blood histamine levels
11/02/2000EP1047418A1 Inhibition of raf kinase using substituted heterocyclic ureas
11/02/2000EP1047417A2 Vanadium (iv) metallocene complexes having spermicidal activity
11/02/2000EP1047416A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis
11/02/2000EP1047411A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
11/02/2000EP0934746A4 Substance in the form of an aqueous extract of vegetal raw material for treating oncological diseases, and method for producing the same
11/02/2000EP0774963B1 Pharmaceutically stable oxaliplatinum preparation
11/02/2000EP0766679A4 Bioactive acetogenins and derivatives
11/02/2000CA2377135A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000CA2371662A1 Peptide homodimers and peptide heterodimers, derived from interferon .alpha.2
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2371165A1 Vitamin d analogues and their pharmaceutical use
11/02/2000CA2371114A1 Death domain containing receptors
11/02/2000CA2370653A1 Pharmaceutical compositions of tetrac and methods of use thereof
11/02/2000CA2370547A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000CA2370387A1 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same
11/02/2000CA2370298A1 Peptide homodimers or peptide heterodimers derived from interleukin 12
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2370043A1 Liposome bonded with antibody and polyalkylene glycol
11/02/2000CA2369999A1 Enzymatically activated polymeric drug conjugates
11/02/2000CA2369951A1 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers
11/02/2000CA2369910A1 Compositions and methods for treatment of hyperproliferative diseases
11/02/2000CA2369092A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000CA2368205A1 N-protected amines and their use as prodrugs
11/02/2000CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same
11/01/2000CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition
11/01/2000CN1271733A CpG oligonucleotide with specific immunostimulation activity to human immune cell
11/01/2000CN1271729A New beta-caprolactam, process for preparing taxane, and taxanes with side chain
11/01/2000CN1271608A Health-care enzymatic chitosan food
11/01/2000CN1271584A Anticancer Chinese medicine
11/01/2000CN1271583A Chinese patent medicine for treating cancer metastasis
11/01/2000CN1058017C Intermediate for prepariny etoposide
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
11/01/2000CN1058001C 4-Mercaptobenzoylguanidine derivatives
11/01/2000CN1057927C Health products able to suppress tumour cell
11/01/2000CN1057919C Medicinal preparation for treatment of tumour
11/01/2000CN1057914C Cancer treating pill and its preparing process
10/2000
10/31/2000US6140492 Antisense transcript expressed in B lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
10/31/2000US6140488 Ras-binding protein (PRE1)
10/31/2000US6140467 Ligand for herpes simplex virus entry mediator and methods of use
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140372 Acyl derivatives of melatonin and of melatoninergic analogues and their use as medicinal products
10/31/2000US6140363 Administering rosmarinic acid, its derivative or prunella vulgaris extract for suppressing immune response for treatment, prevention, or diagnosis of rejection of transplanted organ or tissue, chronic rejection
10/31/2000US6140362 Method for inhibiting the growth of mammalian cells
10/31/2000US6140353 Used as medicaments for the treatment and/or prevention of thromboses, apoplexy, cardiac infarction, inflammation and arteriosclerosis or as antitumor agents
10/31/2000US6140332 Pyrrolopyrimidines and processes for the preparation thereof
10/31/2000US6140328 Heterocyclic cytotoxic agents
10/31/2000US6140317 Pyrrolopyrimidines and processes for their preparation
10/31/2000US6140313 Butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
10/31/2000US6140125 Antisense inhibition of bcl-6 expression
10/31/2000US6140081 Nucleotide binding polypeptide; for efficient use as diagnostic tools in gene therapy and transgenic cells
10/31/2000US6140068 Compositions of the present invention are based on the discovery that peptides containing the amino acid sequence phsrn promote wound healing
10/31/2000US6140058 Activation of p53 protein
10/31/2000US6140052 Diagnosing and treating cancers by determining the presence or absence in a cell of wild-type adenomatous polyposis coli (apc) or a wild-type downstream protein in the apc transcription regulatory pathway
10/31/2000US6139856 Composition useful for providing one-step surgical preparation and drape
10/31/2000US6139845 Treating catecholamine secreting tumor by administering a botulinum toxin
10/31/2000US6139841 Activating immune response in an individual for treatment or prevention of cancer
10/31/2000US6139837 ATP-dependent RNA helicase protein
10/31/2000CA2185112C Humanized monoclonal antibodies against human interleukin-4
10/31/2000CA2018875C Production of pyrrolopyrimidines and intermediates therefor
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063438A2 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000WO2000063406A2 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules
10/26/2000WO2000063395A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000WO2000063393A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000WO2000063378A2 Zalpha13: a human secreted protein
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063368A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000WO2000063364A2 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000WO2000063363A1 Peptide from antigen muc-1 for triggering an immune response to tumor cells
10/26/2000WO2000063352A2 Human homologues of fused gene
10/26/2000WO2000063351A2 Carbohydrate-modifying enzymes
10/26/2000WO2000063348A2 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/26/2000WO2000063251A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000WO2000063249A1 Polypeptides derived from endostatin exhibiting antiangiogenic activity
10/26/2000WO2000063247A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000WO2000063246A2 Compounds and methods for modulating beta-catenin mediated gene expression
1 ... 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 ... 2211